ArticleEvidence-based complementary and alternative medicine : eCAM2017
Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Antifungal activity ofCurrent medical mycology · 2023Article
- 2-Hydroxychalcone as a Potent Compound and Photosensitizer Against Dermatophyte Biofilms.Frontiers in cellular and infection microbiology · 2021Article
- Tannic Acid Accelerates Cutaneous Wound Healing in Rats Via Activation of theAdvances in wound care · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimDermatophytosis is one of the main fungal diseases in humans and animals all over the world.
methodsThe treatment effects of GCS were evaluated by mycological cure rates and clinical score comprised of three indices, including inflammation, hair loss, and lesion scale.
resultsThe results showed that, in the three models of dermatophytosis, GCS significantly (
conclusionThe GCS has antidermatophytosis effect in dogs, which may be a candidate drug for the treatment of dermatophytosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.